|
Agency: Federal Trade Commission
Date: 29 January 2016 |
Under the order, first announced in December 2015, Drug Testing Compliance Group must stop communicating with its competitors about prices, and is barred from soliciting, entering into, or maintaining an agreement with any competitor to divide markets, allocate customers, or fix prices; and from urging any competitor to raise, fix, or maintain prices, or to limit or reduce service. The Commission vote approving the final order was 4-0. (FTC File No 151 0048; the staff contact is William Lanning, Bureau of Competition, 202-326-3361)
The Federal Trade Commission works to promote competition, and protect and educate consumers. You can learn more about how competition benefits consumers or file an antitrust complaint. Like the FTC on Facebook, follow us on Twitter, read our blogs and subscribe to press releases for the latest FTC news and resources.